Abstract | OBJECTIVE: METHODS: Sera of 598 patients with an initial diagnosis of type 2 diabetes (T2DM) were screened for GADA with radioligand assay. These patients were divided into LADA and T2DM groups according to the titers of GADA to compare the prevalence of MS; the proportions of LADA in diabetic patients with and without MS were studied. We also compared the clinical characteristics of LADA patients with and without MS. RESULTS: About 23.7% of the LADA patients had MS. In patients with MS, the prevalence of LADA was 10.0%, of which approximately 95% had low GADA titers, that was, belonging to LADA-type 2. Compared with LADA patients with MS, LADA without MS were similar to classical type 1 diabetes and had features of low body weight, tendency to develop ketosis and impaired islet cell function. CONCLUSION: About 23.7% patients with MS are found in LADA patients. The GADA levels in LADA patients with and without MS are significantly different, which may need different therapeutic strategies.
|
Authors | Xia Li, Zhi-guang Zhou, Lin Yang, Gan Huang, Xiang Yan |
Journal | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
(Zhongguo Yi Xue Ke Xue Yuan Xue Bao)
Vol. 25
Issue 6
Pg. 676-9
(Dec 2003)
ISSN: 1000-503X [Print] China |
PMID | 14714310
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Autoantibodies
- Glutamate Decarboxylase
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Autoantibodies
(immunology)
- China
(epidemiology)
- Diabetes Mellitus, Type 1
(epidemiology, immunology)
- Diabetes Mellitus, Type 2
(immunology)
- Female
- Glutamate Decarboxylase
(immunology)
- Humans
- Male
- Metabolic Syndrome
(epidemiology, immunology)
- Middle Aged
- Prevalence
|